Trial Profile
Exploratory study of AC-262271 in patients with glaucoma
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs AC 262271 (Primary)
- Indications Glaucoma
- Focus Adverse reactions
- Sponsors Allergan
- 12 May 2016 New trial record